Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
For both induction of remission and in maintenance of remission, different doses and
treatment durations are used in practice. The aim of this study is to assess how mesalazine
is used in clinical practice, at which doses and for how long and how these differences
impact the patient disease state and work productivity.